Interested candidates include Canonsburg, Pa.-based Mylan, Ahmedabad, India-based Torrent Pharmaceuticals and Petah Tikva, Israel-based Teva Pharmaceuticals.
Bayer’s dermatology products include Desonate, used to treat eczema, and Finacea, a treatment for rosacea. The business could sell for as much as $1.1 billion, according to the report.
More articles on supply chain:
Amgen, Arrowhead Pharma to collaborate on gene-silencing drugs
Uber to develop technology to connect truckers and carriers
CMS warned Mylan about EpiPen rebate issues multiple times
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
